AZN : Summary for Astrazeneca PLC Common Stock - Yahoo Finance

U.S. Markets close in 5 hrs 23 mins

AstraZeneca PLC (AZN)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
28.08-0.42 (-1.46%)
As of 10:37AM EST. Market open.
People also watch
GSKNVSSNYLLYBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close28.50
Open28.23
Bid0.00 x
Ask0.00 x
Day's Range28.08 - 28.31
52 Week Range25.55 - 35.04
Volume762,620
Avg. Volume7,622,898
Market Cap72.26B
Beta0.56
PE Ratio (TTM)32.10
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.90 (3.16%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters5 hours ago

    GSK grabs Astra executive to replace pharma head

    LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.

  • AstraZeneca Offers Update on Immuno-Oncology Program
    Zacksyesterday

    AstraZeneca Offers Update on Immuno-Oncology Program

    AstraZeneca (AZN) provided an update on its late-stage immuno-oncology program for first-line NSCLC.

  • FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink
    Investor's Business Daily2 days ago

    FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    The FDA's track record for oncology "hits" bodes well for Merck's Keytruda plus chemo combo, Leerink says.